GlassScriptPhysician profile
Jeffrey A Crook
NPI 1730180324
$6,213.32
in general payments reported to CMS, 2019-2025
29 companies · $465 in 2025
The $465 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,801 · 2020: $1,200 · 2021: $951 · 2022: $901 · 2023: $586 · 2024: $309 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,359.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,571.55 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $596.62 | 2019-2024 | Xarelto |
| Medtronic, INC. | $581.08 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Symplicity G3 |
| Novartis Pharmaceuticals Corporation | $415.12 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $366.18 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $328.02 | 2019-2023 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $307.32 | 2019-2023 | Opsumit |
| Abbott Laboratories | $273.68 | 2021-2023 | Mitraclip |
| Boston Scientific Corporation | $252.78 | 2019-2020 | |
| Amgen INC. | $193.94 | 2019-2024 | Repatha |
| Philips North America LLC | $170.35 | 2022-2025 | (Ck4) Mcot, Extended Holter, Ecc Solutions |
| Novo Nordisk INC | $135.54 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $134.97 | 2022-2025 | |
| Amarin Pharma, INC. | $133.10 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $107.23 | 2019-2023 | Camzyos |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $104.28 | 2019-2023 | Lifevest |
| Cvrx, INC. | $103.51 | 2022 | |
| Sanofi-Aventis U.S. LLC | $96.53 | 2019-2023 | |
| Esperion Therapeutics, INC. | $65.43 | 2020-2021 | |
| Kestra Medical Technology Services, INC. | $63.96 | 2024 | Assure Wcd |
| Merck Sharp & Dohme LLC | $41.20 | 2021-2022 | |
| Abiomed | $31.91 | 2023 | Impella |
| Inari Medical, INC. | $26.95 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Irhythm Technologies, INC. | $24.82 | 2019-2020 | |
| Vifor Pharma, INC. | $18.91 | 2019 | |
| Chiesi USA, INC. | $17.96 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.94 | 2022 | |
| Baxter Healthcare | $16.84 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Crook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.